Business Context and Reporting Period
This Form 8-K Current Report was filed by IRADIMED CORP on July 29, 2019. The filing discloses significant changes to the Company's executive leadership and Board of Directors, effective August 19, 2019.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on executive appointments and compensation arrangements.
Material Changes
- Leadership Transition: Leslie McDonnell was appointed President and Chief Executive Officer, succeeding Roger Susi.
- Role Change: Roger Susi will resign as President and CEO but will continue as Chief Technology Officer effective August 20, 2019.
- Board Expansion: The Board of Directors increased its size to five members, with Ms. McDonnell appointed to fill the new vacancy.
Guidance, Outlook, and Compensation Details
The filing details new employment agreements for both executives, outlining significant compensation packages:
- Leslie McDonnell (New CEO):
- Base Salary: $400,000 per year.
- Annual Cash Bonus: Targeted at 100% of salary.
- Annual Equity Bonus: Targeted at $500,000 in restricted stock units (RSUs).
- Sign-on Equity: $2,000,000 in RSUs vesting over four years and stock options for 50,000 shares.
- Severance: 12 months' base salary for termination without cause; 18 months' base salary for termination for good reason following a change of control.
- Roger Susi (New CTO):
- Base Salary: $289,931 per year.
- Annual Bonus: Targeted at 75% of salary, subject to Board discretion and Company profitability.
- Severance: 12 months' base salary for termination without cause; 3x annual salary for termination for good reason following a change of control.
Management commentary indicates Ms. McDonnell's extensive experience in medical devices is intended to improve financial performance and drive shareholder value.
Investor Verification Checklist
- Verify the exact vesting schedule and performance conditions for the $2,000,000 RSU grant to Ms. McDonnell in the attached Exhibit 10.1.
- Confirm the specific definition of "good reason" and "change of control" within the employment agreements to understand severance triggers.
- Review the Company's 2014 Equity Incentive Plan to ensure sufficient shares are available for the new grants.
- Monitor the transition period starting August 19, 2019, for any operational disruptions or strategic shifts announced by the new CEO.